Also found in: Medical.
TURBTTransurethral Resection Bladder Tumor
References in periodicals archive ?
This study was performed on patients scheduled to undergo TURBT at Imam Reza Hospital (Tabriz, Iran) during a 6-month period, as of June 2016.
Methods: A decision and cost-effectiveness model with a five-year time horizon following initial TURBT was used.
An immediate intravesical instillation of a chemotherapeutic agent, such as mitomycin-C or epirubicin, following TURBT is also effective at preventing tumor recurrence in patients with low-risk tumors (Babjuk et al.
However, frequent recurrence (50~70%) and progression (10~20%) rates after TURBT are a major concern [61,73].
TURBT was conducted again 2 months later and histopathology report revealed mucosal ulceration with variable mixed inflammatory cells in the left lateral wall tissue and low-grade papillary urothelial carcinoma PT1a (invasive into lamina propria) at the bladder neck tissue.
5], 104 patients with muscle-invasive bladder cancer underwent TURBT after 3 cycles of M-VAC chemotherapy and 49% of the cohort achieved cT0 after NC.
70 Percent of superficial TCC recur after TURBT and 25 Percent will progress to more invasive forms 6.
TURP, TURBT, PCNL and cystoscopies were the operations taken to be representative of endoscopic manipulation of the genitourinary tract.
The material studied in TURBT specimens is often small and scarce, with cauterization artifacts.
The patient underwent TURBT again and the tumour tissue was sent for histopathologic examination.
Contraindications to its use include hypersensitivity, myelosuppression, thrombocytopenia, and presence of bladder perforation in the post-op TURBT setting (Lamm et al.